This week’s Medicare updates include the extension of a final rule on improvements for acute care and critical access hospitals, an OIG report on potential abuse and neglect at skilled nursing facilities, a revision to the July update of HCPCS codes, and more!
It can be impractical for medical researchers to seek authorization from all the patients whose medical records are sought for a study. That’s why HIPAA allows researchers to use de-identified PHI from records without individual authorization.
Q: Our clinical trial claims often hit edits for missing drugs or devices when those are supplied by the trial sponsor and we can't bill for them. We've been manually reviewing these edits. Is there a recommended method for handling these types of edits that's more efficient?
